Disseminated Cryptococcosis
Article Sidebar
Main Article Content
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Bennett JE. Cryptococcosis. In: Fauci AS,Braunwald S, Kasper D, Hauser SL, Longo DL, Jameson JL,editors. Harrison's principles of intermal medicine. 15th ed. Philadelphia: McGraw-Hill 2001; p.1174-5.
Cryptococcosis. Available from: URL: http//www.doctorfungus.org/mycoses/human/crypto/cryptococcosis.htm
Kwon-Chung KJ, Wickes BL, Stockman L, Roberts GD, Ellis D, How card DH. Virulence, serotype, and molecular characteristics of environmental strains of Cryptococcus neoformans var. gattii. Infect Immun 1992; 60: 1869-74.
Kaplan W, Bragg SL, Cranes A, Abeam DG.Serotyping Cryptococcus neoformans by immunofluorescence. J Clin Microbiol 1981; 14: 313-7.
Sorreli TC, Brownlee AG, Ruma P, Matile R. Pfeiffer TJ, Ellis DH. Natural environmental sources of Cypto coccus neoformans var. gati. J Clin Microbiol 1996; 34: 1261-3.
Walter JE, Atchison RW. Epidemiological and immunological studies of Cryptococcus neoformans. J Bacteria 1996; 92: 82-7.
Chuck SL, Sande MA. Infectious with Cryptococcus neoformans in the immunodeficiency syndrome. NEngl J Med 1989; 321: 794-9.
Levitz SM, Dupont MP, Small Elt. Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans. Infect Immune 1994; 62: 194-202.
Moox G, Perfect JR. Cryptococcal meningoencephalitis in non-HIV infected patients. Uptodate 2004. version 12.2.2.
Hofman V, Venissac N, Mouroux C, Butori C, Mouroux J, Hofman P. Dissemianated pulmonary infection due to Cryptococcus neoformans in non immunocompromised patient. Ann Pathol 2004; 24: 187-91.
Fahurst RM, Pegues DA. Images in clinical medicine: Pulmonary cryptococcal granuloma. N Engl J Med 2002; 347: 497.
Roebuck DJ, Fisher DA, Currie BJ. Cryptococcosis in HIV negative patients findings on chest radiography. Thorax 1998; 53: 554-7.
Mayaud C, Cadranel J.A persistent challenge the diagnosis of respiratory disease in the non AIDS immunocom promised host occasional reviews. Thorax 2000; 55: 511-7.
Lacomis JM, Costello P, Vilchez R, Kusne S. The radiology of pulmonary cryptococcosis in tertiary medical center. J Thorac Imaging 2001;16:139-48.
Chechani V, Kambolz SL. Pulmonary manifestations of dissemimated cryptococcosis in patients with AIDS. Chest 1990; 98: 1060-6.
Dimino-Emme L, Gorevitch AW. Cutaneous manifestations of disseminated cryptococcosis JAAD 1995; 32: 844-50.
Burch KH, Fine G, Quinn EL, Eisses JF. Cryptococcus neoformans as a cause of lytic bone lesions. JAMA 1975; 231: 1507-9.
Monteil MA, Henderson DC, Dev D, Basran GS, Slater D, Taylor P, et al. Immunodeficiency without HIV clinical presentations vary. BMJ 1994; 308:1436.
Sanchez-Albisua B, Rodriguez-Peralto JL, Romero G, Alanso J, Vanaclocha F,Iglesias L. Cryptococcal cellulitis in an immunocompetent host. JAAD 1997;36:450:450- 72.
Dorvault C, Pascuelle WA, Anhalt JP, Richert CA. Final Diagnosis Disseminated Cryptocococcosis (Severe headache and Fever). Availablefrom:URL:http://path.upmc.edu/cases/case 57/dx.html
Kim DY, Kim Y, Baek SY, Yoon HK. Simultaneous
thoracic and abdominal presentation of disseminated cryptococcosis in two patients without HIV infection. AJR 2003; 181: 1055-7.
Morkowitz LB, Kory P, Chanj JC, Haverkos HK, Conley FK, Hensly GT. Unusual causes of death in Haitians residing in Miami, high prevalence of opportunistic infections. JAMA 1983; 250: 1187-91.
Bennett JE, Dismukes WE, Duma RJ, Medoff G, Sande MA, Gallis H , et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 1979; 301:26-31.
Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, William G, et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2000; 30: 710-8.
Diamond DM, Bawer M, Daniel BE. Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of Murine cryptococcal meningitis. Antimicrob Agents Chemother 1998;42: 528-33.
Ellis D. Amphotericin B spectrum and resistance. Antimicrob Agents Chemother 2002; 49: 7-10.
Powdevly WG, Saag MS, Cloud GA. A controlled trial of fluconazole amphotericin B in to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The AIDS clinical trials group and Mycoses study group. N Engl J Med 1992;
: 565-6.
Larsen RA. A comparison of itraconazole versus fluconazole as maintenance therapy for AlDS associated cryptococcal meningitis. Clin Infect Dis 19999, 2978.
Van der Horst CM, Saag MS, Cloud GA. Treatment of cryptococcal meningitis associated with acquired immunodeficiency syndrome. National institute of Allergy and Infectious Diseases Mycoses study group and AIDS clinical trials group. N Eng! Med 1997; 337: 15-21.
Pappas PG. Therapy of cryptoccal meningitis in non HIV infected Patients. Curr Infect Dis Resp 2001:365-70.
Dismukes WE. Introduction to antifungal drugs. Clin Infect Dis 2000; 30: 653-7.
Goldschmidt H, Dong BJ. Treatment of AIDS and HIV-related conditions. J Am Board Fam Pact 2001; 14: 283-309
Dweller IV, Williams IG. ABC of AIDS: Treatment of infectious. BMJ 2001; 322: 1350-4.
Graybill JR. Lipid formations for amphotericin B. Ann Intern Med 1996; 124: 921-3.